Verified email-pattern data for Fh-Early is currently limited. You can still use the company insights and contact sections below.
FH-EARLY is an innovative research project redefining the early diagnosis, risk management, and care of familial hypercholesterolemia (FH), the most common inherited LDL cholesterol condition.
Duration: from 2025 to 2028
Funding: €7.25M HORIZON grant
Partners: 15 top international institutions
Despite affecting over 30M people globally, incl. 2.5M Europeans, FH remains vastly underdiagnosed, with less than 10% of cases identified. FH-EARLY addresses these challenges through cutting-edge technology and a patient-focused approach to improve early detection, risk stratification, and treatment.
Core Innovations
• Next-Generation Chip Array: An affordable, fast genetic diagnostic tool to uncover FH’s genetic causes.
• Signature Biomarker: A breakthrough for personalized risk assessment & tailored care plans.
• Explainable AI-Driven Integrative Precision Health Profiling (iPHP) Tool: A transparent, predictive AI platform offering actionable insights for shared decision-making between patients and clinicains
Patient-Centric Solutions
FH-EARLY places patients and families, especially younger individuals (16-24), at the centre of innovation. Co-creation ensures solutions are practical, culturally relevant, and tailored to diverse needs. By addressing barriers like health literacy, emotional resilience, and communication, FH-EARLY promotes equitable, real-world care.
Transformative Impact
FH-EARLY aims to save lives, prevent heart attacks, and reduce the EU’s cardiovascular disease burden (€282B annually). By advancing early detection and precision interventions, it supports Europe’s Cardiovascular Health Plan and offers hope to millions with FH for healthier, heart-attack-free futures.
Funded by the European Union (EU) through the European Health and Digital Executive Agency (HaDEA). Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the EU or HaDEA. Neither the EU nor HaDEA can be held responsible for them.
Company Details
- Founded
- -
- Address
- Fh Through International Collaboration And Translational Science.
- Industry
- Research Services
- Website
- http://www.fh-early.eu
Fh-Early Questions
FH-EARLY's website is http://www.fh-early.eu
FH-EARLY's LinkedIn profile is https://www.linkedin.com/company/fhearly
FH-EARLY's industry is
Research Services
FH-EARLY's top competitors are
Matisforce,
Direct Dcis Consortium,
Ajk Global,
Lawg Asociatia Local American Working Group,
Euraxess Australia & New Zealand,
Perfecto - Fh,
Moncyte Health,
Permed Fh,
Aware,
Ai Superconnector.
FH-EARLY's categories are Research Services
FH-EARLY's founding year is 2025
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.